Delia Goletti is the Head of the Translational Research Unit at the National Institute for Infectious Diseases L. Spallanzani-IRCCS (INMI) in Rome, Italy. She also undertakes clinical duties at the outpatient clinic for the Respiratory Infectious Diseases Unit of INMI. Her current research interests include immune pathogenesis, immune diagnostic tests and host-directed therapies for tuberculosis, echinococcosis and COVID-19. Within the World Health Organization, she participates as a tuberculosis expert in research on scientific target product profile (TPP) development for tests for tuberculosis treatment monitoring and optimization.